Not Yet Recruiting PHASE2 INTERVENTIONAL 3-arm
NCT06618391
Local Injection and Systemic Therapy in the Treatment of NSCLC.
Envafolimab and Recombinant Human Endostatin and Recombinant Human Adenovirus Type 5 Intratumor Local Injection Combined With Systemic Therapy in Patients With Advanced NSCLC :a Prospective, Exploratory Phase II Clinical Study Tudy
Sponsor: Henan Cancer Hospital
Conditions
Non-small Cell Lung Cancer
Updated 1 time since 2024 Last updated: Sep 26, 2024 Started: Oct 8, 2024 Primary completion: Mar 2, 2026 Completion: Oct 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE2 clinical study on Non-small Cell Lung Cancer, this trial is actively recruiting participants. The trial is conducted by Henan Cancer Hospital and has accumulated 1 data snapshot since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Henan Cancer Hospital
Data source: Henan Cancer Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.